- DL-Homocystine
-
-
2026-06-05
- CAS:870-93-9
- Min. Order: 1kg
- Purity: 98%min
- Supply Ability: 500kgs
- DL-Homocystine
-
- $5.00
-
2026-05-21
- CAS:870-93-9
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 300mt/year
- DL-Homocystine
-
-
2025-04-04
- CAS:870-93-9
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 1Ton
|
| | DL-Homocystine Basic information |
| Product Name: | DL-Homocystine | | Synonyms: | Dl-Homocycine;rac-4,4'-Dithiobis[(R*)-2-aminobutanoic acid];dl-homocystine crystalline;DL-4,4'-Dithiobis[2-aminobutyric acid];HOMOCYSTINE, DL-(RG);H-DL-Hcys-OH)2;2-Amino-4-(3-amino-3-carboxy-propyldisulfanyl)-butyricacid;DL- high cystine | | CAS: | 870-93-9 | | MF: | C8H16N2O4S2 | | MW: | 268.35 | | EINECS: | 212-803-5 | | Product Categories: | Amino Acids;Amino Acids | | Mol File: | 870-93-9.mol |  |
| | DL-Homocystine Chemical Properties |
| Melting point | ≥300 °C | | alpha | [α]D20 0±0.5゜(c=2,1mol/l HCl) | | Boiling point | 507.6±50.0 °C(Predicted) | | density | 1.4269 (rough estimate) | | refractive index | 1.6300 (estimate) | | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | | solubility | Aqueous Acid (Slightly). Aqueous Base (Slightly) | | form | powder to crystal | | pka | 1.90±0.10(Predicted) | | color | White to Light yellow | | Water Solubility | 0.2g/L(25 ºC) | | Merck | 14,4735 | | BRN | 1728581 | | Stability: | Stable. Incompatible with strong oxidizing agents. | | Major Application | detection | | InChI | 1S/C8H16N2O4S2/c9-5(7(11)12)1-3-15-16-4-2-6(10)8(13)14/h5-6H,1-4,9-10H2,(H,11,12)(H,13,14)/t5-,6+ | | InChIKey | ZTVZLYBCZNMWCF-OLQVQODUSA-N | | SMILES | N[C@H](CCSSCC[C@H](N)C(O)=O)C(O)=O | | CAS DataBase Reference | 870-93-9(CAS DataBase Reference) | | EPA Substance Registry System | Butanoic acid, 4,4'-dithiobis[2-amino-, (2R,2'R)-rel- (870-93-9) |
| WGK Germany | 3 | | TSCA | TSCA listed | | HS Code | 2930.90.9250 | | Storage Class | 11 - Combustible Solids |
| | DL-Homocystine Usage And Synthesis |
| Chemical Properties | white to slightly beige solid | | Uses | DL-Homocystine is used in the synthesis of potential antitumor agents through inhibition of L-asparagine. There is growing clinical evidence that elevated homocysteine levels are associated with an increased risk of venous and arterial thrombosis. | | Definition | ChEBI: Homocystine is an organic disulfide obtained by oxidative dimerisation of homocysteine. It has a role as a human metabolite. It is a tautomer of a homocystine zwitterion. | | IC 50 | Human Endogenous Metabolite | | Purification Methods | dl-Homocystine crystallises in platelets from water with 1H2O and m 258-260o(dec), all operations should be carried out under N2. [Sudo J Chem Soc Jpn (Pure Chem Sect) 79 81, 86, 87 1958, Beilstein 4 IV 3199.] |
| | DL-Homocystine Preparation Products And Raw materials |
|